The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
from Times of India https://ift.tt/2Qt0Zt3
महाराष्ट्रातील चालू घडामोडी तात्काळ देणार नेटवर्क Maharashtra Darshan live News
Ads
Subscribe to:
Post Comments (Atom)
BJP’s Rajya Sabha strength falls below 100; may rise soon
A month after touching the mark of 100 seats for the first time in Rajya Sabha, BJP’s numerical strength has come down to 95 as five of its ...
-
सिडनी: भारतीय संघातील अनुभवी अष्टपैलू खेळाडू () याला ऑस्ट्रेलियाविरुद्धच्या तिसऱ्या कसोटीत दुखापत झाली. त्यामुळे तो दुसऱ्या डावात गोलंदाज...
-
As per pre-departure requirement for UAE travelers, the three, including 13-week pregnant Rukhsar, took Rapid RT-PCR tests outside KIA and s...
No comments:
Post a Comment